Germline polymorphisms in genes involved in the IGF1-pathway predict efficacy of cetuximab in wild-type KRAS mCRC patients

Por Winder, Thomas, Zhang, Wu, Yang, Dongyun, Ning, Yan, Bohanes, Pierre, Gerger, Armin, Wilson, Peter M., Pohl, Alexandra, Mauro, David J., Langer, Christiane, Rowinsky, Eric K., Lenz, Heinz-Josef
Publicado em 2010

Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer

Por Loupakis, Fotios, Yang, Dongyun, Yau, Linda, Feng, Shibao, Cremolini, Chiara, Zhang, Wu, Maus, Martin K. H., Antoniotti, Carlotta, Langer, Christiane, Scherer, Stefan J., Müller, Thomas, Hurwitz, Herbert I., Saltz, Leonard, Falcone, Alfredo, Lenz, Heinz-Josef
Publicado no J Natl Cancer Inst (2015)

Phase I and Pharmacokinetic Study of Cetuximab and Irinotecan in Children With Refractory Solid Tumors: A Study of the Pediatric Oncology Experimental Therapeutic Investigators' Co...

Por Trippett, Tanya M., Herzog, Cynthia, Whitlock, James A., Wolff, Johannes, Kuttesch, John, Bagatell, Rochelle, Hunger, Stephen P., Boklan, Jessica, Smith, Amy A., Arceci, Robert J., Katzenstein, Howard M., Harbison, Christopher, Zhou, Xiaofei, Lu, Haolan, Langer, Christiane, Weber, Martin, Gore, Lia
Publicado no J Clin Oncol (2009)